Use our IPO calendar to view upcoming IPOs and new IPOs. Assess recent IPO prices and public offering value. Keep track of the latest IPO stocks, news and Initial Public Offering (IPO) analysis.

Investors are on the hunt for the next big thing, and initial public offerings (IPOs) are some of their favorite places to find hot stocks for the year ahead. While the overall track record of ...

Notably, the IPO would be the first by a Tata Group company after the bumper listing of Tata Technologies in 2023. On December 24, Moneycontrol was the first to report that Tata Capital had ...

The primary market will witness opening of three new initial public offerings (IPOs) in the small and medium enterprise (SME) segment on the coming week. Apart from new public issues, the market ...

Among them, Quality Power Electrical IPO from the mainboard segment will also make its debut, which was expected to be listed last week. Let’s take a look at the two new SME IPOs opening for ...

IPOs allow companies to raise capital easily, used for expansion and rewarding equity holders. Investing in IPOs can be risky; prices may vary initially, but some stocks offer high returns. Direct ...

The GMP has remained flat throughout the bidding process. The IPO of Quality Power Electrical Equipments ran for bidding between February 14 and February 18. The company had offered its shares in ...

Taking your company public through an IPO is a crucial step, presenting a unique opportunity to benefit both your business and its investors. Explore the Nasdaq IPO Academy, a program tailored to ...

Quality Power IPO Allotment: The initial public offering (IPO) of Quality Power Electrical Equipments Ltd received muted response from investors. As the bidding period has ended, investors now ...

Wall Street loves a perfectly choreographed IPO, with more shares offered and prices increased in the lead-up to the deal, to signal rising demand. At the climax, shares of newly-listed companies ...

IPO Edge hosted a fireside chat on Feb. 13 from the floor of the New York Stock Exchange during the 12th Annual IPO Summit with Neil Keegan, Chief Executive Officer at Marlinspike. The in-person ...

Septerna stood out from the crowd of biotech IPOs last year due to the lack of clinical data to hand. Now, the data are coming in—and it’s led the biotech to abandon its lead asset.